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Abstract 
Background: Seven chronic disease prevention and management programs were implemented across Quebec with 
funding support from a provincial‑private industry funding initiative. Given the complexity of implementing inte‑
grated primary care chronic disease management programs, a knowledge transfer meeting was held to share experi‑
ences across programs and synthesize common challenges and success factors for implementation.
Methods: The knowledge translation meeting was held in February 2014 in Montreal, Canada. Seventy‑five par‑
ticipants consisting of 15 clinicians, 14 researchers, 31 knowledge users, and 15 representatives from the funding 
agencies were broken up into groups of 10 or 11 and conducted a strengths, weaknesses, opportunities, and threats 
analysis on either the implementation or the evaluation of these chronic disease management programs. Results 
were reported back to the larger group during a plenary and recorded. Audiotapes were transcribed and summarized 
using pragmatic thematic analysis.
Results and discussion: Strengths to leverage for the implementation of the seven programs include: (1) synergy 
between clinical and research teams; (2) stakeholders working together; (3) motivation of clinicians; and (4) the fact 
that the programs are evidence‑based. Weaknesses to address include: (1) insufficient resources; (2) organizational 
change within the clinical sites; (3) lack of referrals from primary care physicians; and (4) lack of access to programs. 
Strengths to leverage for the evaluation of these programs include: (1) engagement of stakeholders and (2) sharing of 
knowledge between clinical sites. Weaknesses to address include: (1) lack of referrals; (2) difficulties with data collec‑
tion; and (3) difficulties in identifying indicators and control groups. Opportunities for both themes include: (1) foster‑
ing new and existing partnerships and stakeholder relations; (2) seizing funding opportunities; (3) knowledge transfer; 
(4) supporting the transformation of professional roles; (5) expand the use of health information technology; and (6) 
conduct cost evaluations. Fifteen recommendations related to mobilisation of primary care physicians, support for the 
transformation of professional roles, and strategies aimed at facilitating the implementation and evaluation of chronic 
disease management programs were formulated based on the discussions at this knowledge translation event.
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Background
There is consensus that meeting the challenges of the 
increasing prevalence of chronic disease with its impacts 
on the health system and patient quality of life will 
require major changes in the health system. In Canada, 
healthcare reform is driven by the increasing burden of 
wait times, comorbidities and cost among others, and has 
involved stakeholders at local, provincial, and the federal 
level. This resulted in a number of initiatives and com-
mitments across the country, including the commitment 
of provincial premiers in 2004 on the future of health 
care [1–6].
At the provincial level, the Ministère de la Santé et 
des Services sociaux (MSSS) of Quebec has made the 
prevention and management of chronic diseases a pri-
ority by developing and disseminating a strategy for 
the prevention and management of chronic diseases 
to all health and social services agencies (ASSS) and 
by mobilizing the Fonds de recherche Québec—Santé 
(FRQS), the provincial health research funding agency 
for peer-review competitions. The intended purpose 
was to recognize and support best practices and their 
integration into a continuum of services, and to mobi-
lize all stakeholders concerned with chronic diseases 
around the following objectives and outcomes: (1) 
reduce the risk factors that contribute to chronic dis-
ease; (2) reduce the complications of chronic diseases; 
(3) reduce hospitalizations and emergency stays for 
people with chronic diseases; (4) improve the use of 
drugs; (5) improve patients’ quality of life and satisfac-
tion with chronic disease prevention and management 
programs as well as the satisfaction of those who care 
for them; (6) provide individuals with self-management 
support; (7) improve the satisfaction of professionals in 
their daily clinical practice; and (8) improve the health 
of the population [7].
The Pfizer‑FRQS‑MSSS initiative for the prevention 
and management of chronic disease
The Fonds Pfizer-FRQS-MSSS sur les maladies chro-
niques fund was established in 2011 to support innova-
tive projects, driven by local health and social services in 
collaboration with health researchers. This two-part pro-
gram was set up to fund projects aimed at implementing 
initiatives related to the prevention and management of 
chronic diseases (clinical component), and evaluation of 
these initiatives (evaluative component).
Funded projects needed to meet the following con-
ditions: (1) submitted by one or more health and social 
services centers (CSSS) in collaboration with one or more 
family physicians practicing at the primary care level, and 
one or more researchers in the field of health and social 
services; (2) promote a patient-centered interdisciplinary 
approach for the management of individuals with chronic 
diseases at an intensity appropriate to their health con-
ditions, and/or promote the development of tools and 
approaches for self-management support; (3) include a 
process for formal scientific review so that factual data 
and evidence can be gleaned at various stages of the pro-
ject, and so that the efficacy, productivity and/or effi-
ciency of the proposed approaches or courses of actions 
can be assessed. The evaluation should also produce 
knowledge and lessons for other clinical settings that may 
wish to implement the initiatives or tools developed [8].
To date seven projects were funded. The current report 
aims to summarize a 1  day knowledge transfer meeting 
organized to share preliminary results and discuss ways 
to transfer the knowledge gained to other CSSS, and 
ASSS, and maximize the use of evidence from the Que-
bec context. The agenda of the meeting (see Additional 
file 1) included the presentation of the programs followed 
by small group discussions around two themes: (1) suc-
cess factors and challenges of the implementation of 
chronic disease management and prevention programs, 
and (2) lessons learned from the evaluation of the imple-
mentation and effectiveness of each program. The follow-
ing report presents an overview of each of the projects, 
highlighting similarities and differences between them 
to provide context to the results of the round table dis-
cussions. The overarching objective was to highlight the 
common experiences and generate key messages to opti-
mize the implementation and evaluation of chronic dis-
ease management programs.
Characteristics of the seven programs
The evaluation and selection of the research proposals 
were carried out by the Fonds de recherche du Québec—
Santé (FRQS), the provincial funding agency. The seven 
funded programs included are listed below. Details of 
each program are found in Table 1.
P1 Implementation and evaluation of an integrated pri-
mary care network for prevention and management of 
chronic pain
Conclusion: The results from this knowledge translation day will help inform the sustainability of these seven chronic 
disease management programs in Quebec and the implementation and evaluation of similar programs elsewhere.
Keywords: Chronic disease management, Knowledge translation, Implementation, Evaluation
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P2 Evaluation of the implementation of an integrated 
primary care network for prevention and management 
of cardiometabolic risk in Montréal [9]
P3 TRANSforming InTerprofessional clinical practices 
to improve cardiovascular disease prevention in pri-
mary care [10, 11]
P4 Intersectoral and interdisciplinary management of 
type 2 diabetes
P5 Adaptation, implementation and evaluation of 
rehabilitation services for chronic disease prevention 
and management integrated into primary health care 
[12]
P6 Implementation and evaluation of a pragmatic 
intervention of case management and self-manage-
ment support for frequent users of hospital services 
with chronic diseases [13]
P7 Self-management of health within the territory of 
Rocher-Percé.
Conceptual framework
The Chronic Care Model (CCM), an evidence-based 
framework for the management of chronic diseases that 
describes the interaction between the health care set-
ting, community and patient as they relate to health 
outcomes, is informing the implementation of disease 
management and prevention strategies across Canada. 
It has been adopted by the MSSS’s strategy for the pre-
vention and management of chronic diseases. All but one 
program was directly based on the CCM. P6 was based 
on the model of the UK National Health Service on inno-
vation in health care and social services for people with 
CD [14]. “This model incorporates the basic principles of 
the Chronic Care Model [15, 16], while also drawing on 
lessons learned from US models, such as that of Kaiser 
Permanente, with regard to the intensity of care that is 
appropriate for the complex needs of patients [17], and 
of the Evercare model [18], with regard to the use of case 
management nurses in primary care” [13]. Table  2 pre-
sents the empirically supported components of the CCM, 
with an indication of the components applied by each of 
the programs.
Program clinical process and interventions
All of the programs use different combinations of inter-
ventions to achieve their specific goals. The interven-
tions in programs P1, P2 and P4 have many similarities; 
they are based on interdisciplinary team care, standard-
ized clinical process, support for primary care physicians 
and for patient self-management support, and coordina-
tion of care across levels. P4 also includes ‘social market-
ing’ for primary care physicians and online training for 
pharmacists.
In contrast, a clinician, acting as point person, plays 
a central role in the programs P3 and P5. In P3, the pri-
mary care nurse performs the evaluation of the cardio-
vascular health and ensures the referral of the patients 
to other health professionals. P3 also included an inter-
vention, facilitation, specifically developed to support 
program implementation and included the provision of 
internal facilitators represented by clinicians from family 
medicine groups (FMG) and external facilitators. Inter-
ventions for P5 include nurse led interventions for self-
management support, education on diseases (diabetes, 
COPD, asthma, cardiovascular), education on risk factors 
(pre-diabetes, high blood pressure, dyslipidemia, obesity, 
physical inactivity, smoking), motivational interview-
ing, education about nutrition, education about physical 
activity, and counselling on medication use and on smok-
ing cessation.
P7 is organised around a kinesiologist, nurse and nutri-
tionist (K-I-N triad), who as a team provide interdisci-
plinary management and follow-up for individuals with 
chronic diseases in the Rocher-Percé territory. The pri-
mary care nurse holds the pivotal roles of medical and 
pharmacological monitoring and coordination with fam-
ily physicians and specialised services. P6 is a very case-
management oriented program with case management 
by FMG nurses who are charged with: (1) evaluation of 
the patient’s needs and resources; (2) establishment and 
maintenance of a patient-centred, individualized service 
plan; (3) coordination of services among partners; and (4) 
self-management support for patients and families. All 
patients are given the opportunity to participate in self-
management groups based on the Stanford program [19].
Evaluation study design
Program implementation
To evaluate the implementation of the programs, three 
programs used mixed methods (P1, P2, P3), one pro-
gram used a survey method (P4), and one program (P7) 
used only qualitative methods. Finally, two programs 
undertook a realist evaluation and practical participatory 
approach to evaluate the program’s implementation (P5, 
P6).
Impact on patient outcomes
The process for evaluating the impact on patient out-
comes was based on a combination of qualitative and 
quantitative methods in the majority of the programs. 
Three programs (P1, P2 and P7) specifically adopted 
the mixed methods approach with triangulation of the 
data and a quasi-experimental before-after design with 
repeated-measures for patient impact evaluation. A ran-
domized design was used for four programs (P3, P4, P5 
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and P6) and a quasi-experimental before-after design 
with repeated-measures was used for three programs 
(P1, P2 and P5) with a comparison group for one pro-
gram (P5). Various qualitative methods were reported 
by the programs and included participatory and multiple 
case study approaches. P6 also conducted an economic 
analysis looking at cost-effectiveness and the cost-benefit 
of implementing the program.
Outcome measures
Implementation
Table 3 presents the variety of elements considered when 
evaluating the implementation of the programs; these 
elements were grouped into broader categories. While a 
common implementation evaluation model did not exist 
among the seven programs, in general, each considered 
most or all of the elements of each domain. Two excep-
tions exist. The first is that P5 and P6 did not assess sup-
port offered to healthcare professionals in the program 
as part of the implementation evaluation, and the second 
is that only two programs (P3 and P6) initially set out to 
assess the cost of implementation.
Impact on patient outcomes
Table  4 presents measures for the impact evaluations 
for each program. While the specific measurement tools 
used were specific to the chronic disease targeted by the 
program, many of the programs measured similar out-
comes. The impact measures in Table  4 are categorized 
into three sections: patient reported outcomes, clinical 
Table 2 Elements of Chronic Care Model (CCM) included in each program
CCM component P1 P2 P3 P4 P5 P6 P7
Health system
Visibly support improvement at all levels of the organization, beginning with the senior leader √ √
Promote effective improvement strategies aimed at comprehensive system change √ √
Encourage open and systematic handling of errors and quality problems to improve care √ √ √ √
Provide incentives based on quality of care
Develop agreements that facilitate care coordination within and across organizations √ √ √ √ √ √
Delivery system design
Define roles and distribute tasks among team members √ √ √ √ √ √ √
Use planned interactions to support evidence‑based care √ √ √ √ √ √ √
Provide clinical case management services for complex patients √ √ √
Ensure regular follow‑up by the care team √ √ √ √ √ √ √
Give care that patients understand and that fits with their cultural background √ √ √ √
Decision support
Embed evidence‑based guidelines into daily clinical practice √ √ √ √ √ √ √
Share evidence‑based guidelines and information with patients to encourage their participation √ √ √ √ √ √ √
Use proven provider education methods √ √ √ √ √ √
Integrate specialist expertise and primary care √ √ √ √ √
Clinical information systems
Provide timely reminders for providers and patients √ √ √ √
Identify relevant subpopulations for proactive care √ √ √ √ √
Facilitate individual patient care planning √ √ √ √ √ √ √
Share information with patients and providers to coordinate care √ √ √ √ √ √ √
Monitor performance of practice team and care system √ √ √ √ √
Self-management support
Emphasize the patient’s central role in managing their health √ √ √ √ √ √ √
Use effective self‑management support strategies that include assessment, goal‑setting, action planning, 
problem‑solving and follow‑up
√ √ √ √ √ √ √
Organize internal and community resources to provide ongoing self‑management support to patients √ √ √ √ √ √
The community
Encourage patients to participate in effective community programs √ √ √ √ √ √ √
Form partnerships with community organizations to support and develop interventions that fill gaps in  
needed services
√ √ √ √ √
Advocate for policies to improve patient care √ √ √
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outcomes, and use of healthcare services. In terms of 
patient reported outcomes, a wide range of measures 
are used by one or more of the programs to evaluate 
the following constructs: pain intensity and interfer-
ence, physical function, anxiety, depression, quality of 
life, self-management, management of chronic disease, 
psychological distress, social isolation, literacy, patient 
activation, lifestyle habits, and satisfaction with care. 
Many of the blood and physical clinical measures are 
common among four of the seven programs (P2, P3, 
P4, P7) and all seven programs assess use of healthcare 
services.
Table 3 Implementation measures
HP health professionals, CME continuing medical education, CSSS centre de santé et de services sociaux, ACIC assessment of chronic illness care
Domain evaluated Elements considered P1 P2 P3 P4 P5 P6 P7
Resources Community and potential partner organizations in the region ✓ ✓ ✓ ✓ ✓ ✓
Human ✓ ✓ ✓ ✓ ✓ ✓ ✓
Financial ✓ ✓ ✓ ✓ ✓ ✓
Physical space ✓ ✓ ✓ ✓ ✓ ✓
Strategies and approaches (ex. CME) ✓ ✓ ✓ ✓ ✓ ✓
Information sharing ✓ ✓ ✓ ✓ ✓ ✓ ✓
Organizational structure Decision making roles ✓ ✓
Remuneration of health professionals ✓ ✓
Consultation structure within the program ✓ ✓ ✓ ✓ ✓
Establishing links with partners ✓ ✓ ✓ ✓ ✓ ✓
Role of stakeholders in the success of the program ✓ ✓ ✓ ✓ ✓ ✓ ✓
Follow‑up by program clinicians ✓ ✓ ✓ ✓ ✓ ✓
Reach within target population Patients ✓ ✓ ✓ ✓ ✓ ✓ ✓
Referring health professional ✓ ✓ ✓ ✓ ✓ ✓ ✓
Medical clinics ✓ ✓ ✓ ✓ ✓ ✓ ✓
CSSS ✓ ✓
Support for referring HP Continuing medical education sessions ✓ ✓ ✓ ✓ ✓
Development of clinical tools and forms ✓ ✓ ✓ ✓ ✓ ✓ ✓
Communications with referring health professionals ✓ ✓ ✓ ✓ ✓ ✓ ✓
Support for program HPs Formal and informal training sessions ✓ ✓ ✓ ✓
Regional professional committees ✓ ✓
Contextual facilitators and barriers Clinician and stakeholder incentives ✓ ✓ ✓ ✓
Change management strategies ✓ ✓ ✓ ✓ ✓ ✓
Confidence and engagement of stakeholder ✓ ✓ ✓ ✓ ✓ ✓
Organizational structure of the clinic ✓ ✓ ✓ ✓ ✓
Organizational structure of services within CSSS ✓ ✓ ✓ ✓ ✓ ✓
Building collective knowledge and leadership ✓ ✓ ✓ ✓ ✓ ✓ ✓
Appropriation by stakeholder ✓ ✓
CSSS external environment ✓ ✓
Waiting time Delay between reception of the referral to program and the 1st visit ✓ ✓ ✓
Impact on Primary care Participation in the program ✓ ✓ ✓ ✓ ✓ ✓ ✓
Physicians perception of impact on patients ✓ ✓ ✓ ✓ ✓ ✓ ✓
Interprofessional collaboration ✓ ✓ ✓ ✓ ✓
Perception benefit of the program ✓ ✓ ✓ ✓ ✓ ✓ ✓
Improvement of knowledge regarding management of patient with  
chronic condition and resources available
✓ ✓ ✓ ✓ ✓ ✓
Use of CCM components and clinical tools ✓ ✓ ✓ ✓ ✓ ✓
Doctors participating in CME sessions ✓ ✓
Management of individuals with chronic disease (ACIC) ✓ ✓ ✓
Cost Cost‑effectiveness ✓ ✓
Cost‑benefit ✓
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Methods
Round table discussions
Each project team selected at least two members to 
attend the meeting. Participants (n = 75) were a blend of 
15 clinicians, 14 researchers, 31 knowledge users [gov-
ernment decision makers (n  =  25), clinical administra-
tors (n  =  3), university and academic health network 
members (n = 3)], and representatives from the funding 
agencies [Pfizer (n = 5), MSSS (n = 6), and FRQS (n = 4)] 
(see Additional file  2). Verbal consent was obtained by 
all participants at the commencement of the meeting 
proceedings. Each of the participants was assigned to 
one of seven round tables by the organizers of the event 
in order to ensure equal representation of stakeholders 
Table 4 Patient impact measures
HADS Hospital Anxiety and Depression Scale, PACIC patient assessment of chronic illness care, PIH partner in health, ADDQoL audit of diabetes dependent quality of 
life tool, SEM-CD self-efficacy for managing chronic disease, SDSCA summary of diabetes self-care activities measure, DBMA the disease burden morbidity assessment, 
K-6 Psychological Distress Scale, PAM patient activation measure, NVS newest vital sign
Construct Measure P1 P2 P3 P4 P5 P6 P7
Patient reported outcomes
Pain intensity and interference Brief pain inventory ✓
Physical function Oswestry ✓
Anxiety HADS ✓ ✓
Depression HADS ✓ ✓
PHQ‑9 ✓
Self‑efficacy Self‑efficacy scale ✓ ✓
SEM‑CD ✓ ✓
Quality of life SF‑36 ✓
SF‑12 ✓ ✓ ✓
ADDQoL ✓
Level of risk Keele start back ✓
Self‑management (empowerment) HeiQ ✓ ✓ ✓
SDSCA ✓
PIH ✓
Management of chronic disease PACIC ✓ ✓ ✓ ✓ ✓
Co‑morbidity DBMA ✓ ✓
Psychological distress (K‑6) ✓ ✓
Social isolation Nottingham health profile ✓
Literacy NVS ✓
Patient activation PAM ✓ ✓
Lifestyle habits Physical activity ✓ ✓ ✓ ✓ ✓
Smoking ✓ ✓ ✓ ✓ ✓
Eating habits ✓ ✓ ✓ ✓ ✓
Satisfaction with care Interview/questionnaire ✓ ✓ ✓ ✓ ✓
Care experience survey ✓ ✓ ✓
Clinical measures
Blood HbA1C ✓ ✓ ✓ ✓
Blood pressure ✓ ✓ ✓ ✓
LDL‑C ✓ ✓ ✓
Glycemia ✓ ✓ ✓ ✓
Lipid profile ✓ ✓ ✓
Physical Waist size ✓ ✓ ✓ ✓
BMI ✓ ✓ ✓ ✓ ✓
Use of healthcare services
 Patient use of services ER visit ✓ ✓ ✓ ✓ ✓ ✓
Hospitalization ✓ ✓ ✓ ✓ ✓ ✓ ✓
Visits to other professionals ✓ ✓ ✓ ✓ ✓ ✓
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and members of each project team. Each round table, 
consisting of 10–11 participants, was assigned one of 
two themes to consider. Each group was also assigned a 
facilitator who guided the discussions and a rapporteur 
who took notes. At the end of the group discussion it was 
the rapporteur who presented a summary of the round 
table discussions during the larger group session. Each 
round table was asked to identify the strengths, weak-
nesses, opportunities, and threats (SWOT) regarding 
the themes. The larger group report-back session and 
discussion was audio-taped and transcribed. In the week 
following the meeting, two independent reviewers (AG 
and PW) conducted a pragmatic thematic analysis of the 
transcripts [20]. Themes were reviewed and refined by 
the working committee leading the writing of the report 
(SA, RV, AG, PW). The results of the SWOT analysis and 
conclusions that stemmed from this analysis were vali-
dated with members of the follow-up committee, which 
consisted of members from each of the funded projects. 
The committee reviewed the initial version of the synthe-
sis of the SWOT analysis, and comments were integrated. 
The document was circulated until minimal suggested 
revisions were proposed. This knowledge translation 
meeting, and the publication of its results, was exempted 
from requiring ethics committee approval by the McGill 
University Health Centre Research Ethics Board.
Results and discussion
Results of the SWOT analysis for the theme of success 
factors and challenges of implementing chronic dis-
ease prevention and management programs are found 
in Table  5. Results for the SWOT analysis of Theme 2, 
opportunities for cross comparison of results across the 
projects and remaining questions to determine effective-
ness of the projects, are found in Table  6. Even though 
each round table was given different themes to consider, 
given the interdependency between implementation and 
evaluation of the programs, some of the SWOT areas 
were repeated in Theme 1 and 2. In Tables  5 and 6 we 
placed the majority of factors according to whether they 
were most closely related to implementation or evalua-
tion. However, we elected to retain some overlap between 
the two tables when we felt that the repeated areas held 
different implications depending on whether it is viewed 
within the context of implementation or evaluation.
Theme 1: success factors and challenges of the 
implementation of chronic disease prevention 
and management programs
Specific question for Theme 1: What are the key success 
factors and challenges of implementing chronic disease 
management and self-management programs, within 
the context of the seven chronic disease management 
programs? How can we ensure the sustainability of 
chronic disease management programs? Identify the 
strengths, weaknesses, opportunities and threats.
Strengths to leverage
Synergy between clinical and research teams
One of the most important strengths discussed was the 
funding structure (clinical implementation and evalua-
tion component) that allowed for a synergy between the 
research and clinical teams to evolve. These two groups 
working together ensure that a data collection process, 
based on clinically relevant indicators, can take place and 
be efficiently fed back to clinical teams. This synergy is 
reinforced by communication both within and between 
the respective interdisciplinary teams.
Stakeholders working together
Another strength identified was the motivation and 
mobilizations of all stakeholders including healthcare 
professionals, patients, managers, members from the 
CSSS, the ASSS and MSSS, and potential collaborators 
in the private sector. Mobilization itself is made easier if 
there is an intimate understanding of the needs of each 
stakeholder because it will allow for a concerted effort 
towards implementation. Also crucial, and another 
strength that was highlighted, is strong leadership at all 
managerial levels (local, regional, and provincial) to drive 
the projects forward in the face of the numerous chal-
lenges. Another identified strength was the presence 
of a shared vision and philosophy from the community 
about what we want these programs to achieve, to guide 
the development of specific goals (everyone thinking and 
working together towards the same common goal).
Motivated clinicians working together
Other factors that facilitate the implementation include 
the availability of motivated clinicians, and immediate 
embracing of the program by some clinicians, and their 
willingness to go above and beyond what the pilot project 
was meant to implement. The presence of complete clini-
cal teams composed of various professionals allows cli-
nicians to learn from one another, and allows for strong 
clinical leadership within the diverse professions.
Evidence‑based programs
Another important strength is the quality and the nature 
of the program structures themselves. While no two 
programs are identical, they are born out of one com-
mon evidence-based model, such as care being centered 
on the patient with a consideration of psychosocial and 
other risk factors, an emphasis on self-management, and 
a strong interdisciplinary component. There is there-
fore common ground for projects to learn from one 
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Table 5 Results of SWOT analysis for the implementation of chronic disease prevention and management programs
Strengths to leverage Weaknesses to address
Stakeholders, partnerships, and knowledge transfer Funding
Having a “complete picture” and understanding [needs] of key  
stakeholders, including decision‑ makers and their willingness to support 
change
Length of project is too short to make a clinical or behavioural change in 
patients
Strong government leadership (local, regional, and national) Evaluation component is under financial and evaluation constraints bring‑
ing delays in patient interventions
Clinicians and clinical teams Lack of resource and funds (local, regional, and national)
Motivated clinicians
 Immediate embracing of the program by some clinicians—willingness to 
go above and beyond what the pilot project was meant to implement
Funding required sites to commit to the longevity of programs before 
programs were proven to be effective
Communication
Lack of communication/marketing plan aimed at reaching target popula‑
tions
The presence of complete clinical teams composed of various  
professionals allows clinicians to learn from one another
Strong clinical leadership in the diverse professions Ineffective communication of teams in primary care and no systematic 
communication with referring doctors
Program structure Clinicians and clinical teams
A common model of care between projects
 Ability of a program to integrate into existing structures. Projects need to 
be able to weave a place into what already exists
Have a tendency to use “champion clinicians”. There is a danger in counting 
on “champions” who are not always available
Existing medical culture closed to the concept of interdisciplinary and 
preventative interventions
Nature of the programs is evidence‑based Recruitment and turnover of personnel is especially difficult in a perspec‑
tive of trying to transform clinical roles
 Address diseases as well as their risk factors Lack of participation from referring physicians
 Patient‑centered approach compared to a typical silo approach Program structure
 Touch on psychosocial factors as much as biological factors Many tools available make the decision about choosing which one to use 
difficult
 Emphasis on interdisciplinary teams, and self‑management Not having clinical information systems
Low number of referrals to the programs. May be due to lack of awareness 
of referral forms or clear referral procedures
Method of physician remuneration
Lack of continuity of care
Opportunities to optimize Threats to mitigate
Funding
Seize public and private funding opportunities Funding
Capitalize on existing funding to add resources to Family Medicine  
Groups
Ensure continuation of funding
Explore what currently exists in terms of remuneration models Lack of resources and difficulty of resources management
Stakeholders, partnerships, and knowledge transfer Ensuring constant and continuous data collection
Facilitate intra and inter‑professional meetings for knowledge exchange  
and ensuring human contact between stakeholders
Stakeholders, partnerships, and knowledge transfer
Integration of many organizations with different business models and 
cultures—brings challenges in terms of communication, authority, 
financing, etc
Working with people and community networks who have a shared vision 
and philosophy
 Influence changes in university curriculum to put greater emphasis on 
interdisciplinarity
Roles and responsibilities described in the law do not necessarily translate 
into real power or influence
Continuously talk about chronic disease in its entirety to incite others to 
associate themselves with the cause
Lobby presence (ex. pharmaceutical, professional federations)
  Mobilization of primary care teams and all the financial factors involved—
resource re‑allocationClinicians and clinical teams
Make better use of clinical tools, stakeholders experience, and models 
which have already proven themselves—avoid reinventing the wheel
Will take effort to compile and disseminate the results of seven projects so 
that they can be used to guide decisions across the province
Capitalize on the synergy between research team and clinicians Clinicians and clinical teams
Strong evaluations and the guidance it can provide throughout the  
implementation process and for guiding future decisions
Potential resistance that arises during the evaluation of clinical practice
Harmonizing the visions in the management of chronic disease (ex. expert 
clinician vs. the patient partner)Support the transformation of professional roles by exploring different  
types of training
Program structure Learning to work in interdisciplinary teams
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another. In addition, there is an increased likelihood 
that stakeholders who subscribe to these principles will 
be motivated to implement the program. Of particu-
lar importance is the ability for a program to be able to 
weave a place for itself and share resources in a health-
care system that is lagging behind in the adoption of 
these chronic disease management principles. The ability 
of the programs in some regions to be able to integrate 
into existing structure was identified as an unexpected 
strength.
Weaknesses to address
Insufficient resources
All groups indicated that the insufficiency of resources 
is an important challenge facing implementation. This 
includes lack of (1) funds on the local, regional, and pro-
vincial levels; (2) inadequate space to implement a given 
program the way in which it was originally intended; (3) 
a high turnover rate of the appropriate human resources 
occupying central roles within the program, and (4) short 
timelines. The timeline of the funding for the projects 
was identified as being too short to adequately imple-
ment the programs, and insufficient to be able to see sig-
nificant clinical and/or behavioural changes in patients. 
Beyond having adequate resources for implementation, 
there needs to be enough resources to ensure a thor-
ough evaluation and to carry this evaluation all the way 
through to the dissemination phase. In fact, the return of 
research results could ultimately be used to motivate all 
stakeholder groups, facilitate implementation, and bring 
about the desired changes of both current and future 
projects.
Organizational change within the clinical sites
Managing organizational changes, including resource re-
allocation that is needed for full implementation of pro-
grams is one challenge that was raised more than once 
during the discussions and should not be underestimated. 
Within a single organization, there is the challenge of 
harmonizing different visions of chronic disease man-
agement. Organizational culture of an establishment can 
hinder implementation in  situations where they do not 
coincide with a program’s philosophy, and become an even 
larger issue as programs begin to expand into larger ter-
ritories. For example, health professionals who do not buy-
into the concept of interdisciplinary care are less motivated 
to participate, which is of particular importance when 
that professional is needed as an integral part of the team. 
Even when everyone is open to change, it is a challenge to 
ensure that all professionals are applying their expertise to 
their full potential in the context of role transformation.
Another challenge identified is the need to balance the 
program and the elements of the CCM within the existing 
organisational structure, whose nature does not match 
with more concrete organization factors. An exam-
ple being that the lack of remuneration of participating 
physicians can be perceived as a financial disincentive in 
the context of many of these chronic disease programs. 
Another related challenge is the potential resistance (by 
clinical teams) that can manifest itself when clinical prac-
tice and quality of care are being evaluated.
All organizational changes require strong leadership. 
Programs have a tendency to use “champion clinicians”; 
however, there is a danger in counting only on “champions” 
who are not always available. Further, a leader and a cham-
pion clinician play a distinct role. The leader’s function is to 
influence opinions of the members of the team, group, or 
establishment. The champion is asked to provide expertise 
and experience to peers regarding the innovative practices 
to be implemented. Implementation may be more success-
ful if those planning the program think through who will 
play each of these roles, and if it will be the same person 
who will assume both roles. Also, if programs are relying 
on leaders who are too conservative, or lack the appropriate 
authority or influence to make the changes, this represents 
an additional weakness. Finally, creating organizational 
change is even more difficult with the high turnover of staff 
experienced by many of the clinical teams.
Table 5 continued
Opportunities to optimize Threats to mitigate
Support integration of self‑management into patient care Lots of sudden changes can become tiresome
Adoption of health information technologies to facilitate referrals, care 
delivery, access to medical information, and communication
Ensure that professionals are using their full potential, particularly in a 
context of the revision of roles
Would be good to have access to a single tool that could facilitate work of 
the doctor and properly identify the patient’s needs and show where  
they are in their care path
Avoiding a doubling of services—make sure projects are not competing 
with existing services on a territory
Physicians often lack a complete health profile of their clientele
Restructure programs to better respond to personnel turnover
A large proportion of the population does not have a family physician and 
therefore no access to these projects
Conservative leadership of authorities—is the leadership sufficient to bring 
about the desired changes?
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Table 6 Results of  SWOT analysis for  evaluating and  communicating the effectiveness of  chronic disease management 
programs
Strengths to leverage Weaknesses to address
Stakeholders, Partnerships, and Knowledge Transfer of evaluation results
Legitimate interest of potential community partners e.g. pharmacists
Sincere interest in the program on the part of referring doctors, stakehold‑
ers, and clinicians
The evaluation provides a natural feedback mechanism. Patients who 
see an improvement in their health bring this information back to their 
family doctors
Evaluation process
Similarity of programs (all based on CCM)
Similarity of tools allows for the pooling of results to increase sample sizes 
and allow for comparison
Funding
Lack of resources for evaluation
Communication
Lack of referrals to the program and difficulty in reaching the target 
population (small sample size)—expressed as a lack of marketing and 
communication skills
Communication procedure are not well defined: need a mechanism to 
feed back patient outcomes to physicians and for them to communicate 
with the program to ask questions and see how their patient is doing
Stakeholders, partnerships, and knowledge transfer of evaluation results
Physicians not convinced about the efficacy of an interdisciplinary 
approach
Difficulty in legitimizing the projects to key actors, often family doctors
Difficulty in feeding back information about evaluation results to clinicians
Evaluation process
Different indicators between projects
 Need to establish key minimal indicators that must be collected through‑
out implementation
Evaluation timeline too short
Short timeline means incomplete implementation
Lost participation leading to missing data
Difficulty involving clinicians in the data collection process
The act of evaluating is seen as an intervention in itself. Good for imple‑
mentation but might introduce bias for evaluation
Unclear definition of chronic diseases (ex. is cancer a chronic disease?)
Cannot ignore notion of cost‑benefits as many stakeholders are interested 
in knowing about the long‑term feasibility at the institution level
Lack of technology‑supported tool
All stakeholders have different things they want to measure, achieve, and 
evaluate. This is hard to consolidate
Opportunities to optimise Threat to mitigate
Stakeholders, Partnerships, and Knowledge Transfer of evaluation results Funding
Improve involvement of family doctors to ensure their participation and 
ensure their sense that they have a role to play
Not enough funding for an evaluation to prove a program’s long‑term 
effectiveness, which is needed to seek more funding
Integration with local and community resources (ex. YMCA, pharmacists, 
gyms, kinesiologists)—need to get creative in terms of partnerships
Make use of evaluation results to legitimize the projects to seek out  
funding and attract involvement of more people
Planning and financing of research—not enough resources to see the 
evaluation all the way through (implementation, evaluation, diffusion of 
results)
Stakeholders, partnerships, and knowledge transfer of evaluation results
Not enough publication of results to help decision makers
Evaluation process
Danger of saturating certain areas with too many similar projects
Synthesize the facilitating factors and challenges experienced by all  
projects
Pursue and create new partnerships by bringing down barriers with the 
community
Utilize existing resources like local regional tables to promote important 
networking opportunities
Bring professionals together to standardize care and information given to 
patients
While there are similarities in evaluation tools, this isn’t always the case—it 
will be a challenge to harmonize tools and projects in the future
Communication
Improve marketing and communication (ex. work with students). This can 
help bring awareness to the project and help researchers disseminate 
results
Clinical information systems could help in data collection—these are not 
available for most projects
Obtaining an adequate control group
Resistance to the evaluation of programs and of quality of care
Improve working conditions for professionals to incite them to participate 
in the program
Evaluation process
Need to evaluate costs ‑ both cost of implementation and cost‑ effective‑
ness of project
Do better job of evaluating physician dropout rates
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Lack of referrals from primary care physicians
The low number of referrals to the programs is an impor-
tant challenge faced by many of the programs. Slow enrol-
ment significantly affects the speed with which programs 
can be fully implemented. This is in part due to logisti-
cal problems, e.g. the fact that program referral forms are 
not ubiquitously available in referring physicians’ offices 
across a project’s territory. In some instances there may 
be a lack of clarity or knowledge of the referral process. 
It could also be that doctors, who have a more traditional 
approach to care delivery, might not yet be convinced of 
the efficacy of an interdisciplinary approach with such 
a large focus being placed on patient self-management. 
Many therefore signal the need for a communication or 
a marketing plan to be put in place to regularly promote 
the program to the target population and their treating 
health professionals. A communication strategy should 
outline the objective/goals of the communication, iden-
tify stakeholders, define key messages, pinpoint potential 
communication methods and vehicles for communicat-
ing information for a specific purpose, and specify the 
mechanisms that will be used to obtain feedback on the 
strategy [21]. The lack of human resources with the skills 
needed to support the selected communication strategy 
may only be one cause for low referring doctor engage-
ment. Another cause might be that the communication 
procedure from the program to the referring doctor is 
difficult to fully implement (e.g. sending written feedback 
reports from the interdisciplinary team to the primary 
care physician to provide information about patient pro-
gress and outcomes). These communication strategies 
can be expanded to allow for a two-way communica-
tion that would allow doctors to contact the program to 
verify patient eligibility for the program or inquire about 
patient outcomes.
Program access
Aside from the challenges facing program implementa-
tion within an organization, it is also important to ensure 
that it is integrated into the existing healthcare system. 
The majority of projects require patients to have family 
doctors, but what will happen to the large proportion of 
the Quebec population who does not have one? In addi-
tion, and contrary to this problem of lack of access, par-
ticipants highlighted that implementing a program might 
bring about a doubling of services that already exist on a 
territory; this needs to be avoided, as it would represent 
an inefficient use of resources.
Theme 2: effectiveness of chronic disease management 
programs
Specific question for Theme 2: What possible opportu-
nities are there for cross comparison of implementation 
and impact evaluation across the projects? Given the 
results of the projects to date, what are the remaining 
questions that need to be answered to determine the 
effectiveness and cost of implementing similar programs?
Strengths to leverage
Engagement of stakeholders
A strong implication, a high level of motivation, and sin-
cere interest on the parts of referring doctors, patients, 
clinicians, researchers and all other stakeholders facili-
tates the program evaluation as they all have a role to 
play in data collection, result interpretation, and dissemi-
nation. This engagement is maintained through a strong 
communication amongst all parties. Another strength 
that helps engage the less motivated referring physicians 
is when satisfied patients who see an improvement in 
their health convey this satisfaction to their family doc-
tors thereby offering tangible evidence of the program’s 
effectiveness.
Learning from the similarities and differences 
between programs
The other major strength is the opportunity to inform 
the evaluation of the impact of the chronic disease man-
agement programs by considering the similarities and 
the differences between projects. The similarities allow 
for the sharing of common tools among multiple pro-
grams, which offers the possibility of comparing results 
and increasing sample sizes when evaluating impact on 
patient outcomes and primary care practice. While pos-
sible comparisons of results between projects should be 
explored further, caution is needed given the differences 
in patient populations and program objectives across 
projects. The different implementation strategies can be 
compared to identify the most effective components of 
these strategies.
Weaknesses to address
Lack of referrals
Lack of referrals to the program, while hindering pro-
gram implementation, also directly effects the evalua-
tion by not having a large enough sample. This problem 
is compounded when participants leave the program 
early causing a situation of missing data. The slower the 
enrolment, the greater the delay the evaluation team has 
in being able to provide meaningful results. Many par-
ticipants expressed the pattern whereby lack of partici-
pating patients tends to add to a difficulty in legitimizing 
and supporting the program’s advantages, and, in turn, 
family doctors are not encouraged to refer due to lack 
of evaluation results. In addition, it is often difficult to 
provide evaluation results to clinicians in a timely man-
ner to support them in identifying ways to enhance the 
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implementation of the programs and to assess the impact 
on patient care and to inform clinical decisions.
Barriers to program implementation
Many challenges affecting the implementation of pro-
grams were also evoked when participants discussed the 
evaluation theme. In addition to a lack of referrals to the 
program, others include: the difficulties in having all the 
appropriate resources (financial, human, space) neces-
sary for implementation; a lack of access for patients who 
do not have a family doctor; cultural differences; and a 
short timeline for program implementation. In addition 
to this latter point is the consensus that evaluation time-
frames are also too short to complete evaluations capable 
of showing meaningful results for dissemination.
Data collection
Data collection represents a significant challenge to 
demonstrating the program’s effectiveness and there 
are many factors contributing to this problem. The first 
is that drop outs by participating patients or clinicians 
before the completion of the program leads situations of 
missing data. Second, while the presence of such a com-
prehensive evaluation component can help with imple-
mentation of the programs by motivating stakeholders, if 
clinicians change their behaviour because they know they 
are being evaluated, it may also represent an important 
bias that will need to be accounted for in the interpreta-
tion of results. Nevertheless, these research projects are a 
unique opportunity for developing a culture of evaluation 
and improvement in primary care. The evaluation should 
therefore not be envisioned nor used as a “police” looking 
for mistakes and failures. Third is the fact that clinicians 
are being asked to play a central role in the data collec-
tions process which is something that is not traditionally 
part of their professional roles, therefore, there is some-
times a resistance or unwillingness to do so. Fourth is the 
lack of information technologies, which have the potential 
to greatly facilitate the data collection and management 
processes. In fact, if clinical information systems were 
present for all programs, it is likely that clinicians would 
see the burden of participating in data collection reduced.
Identifying indicators and appropriate control groups
A context in which many stakeholders have a voice in the 
selection of which data is to be collected was identified 
as a potential weakness. In fact, all stakeholders have dif-
ferent objectives, and want to measure different things. 
Therefore, the challenge is consolidating these needs 
and making decisions on which tools to use and which 
indicators to collect while keeping in mind the resource 
constraints of the evaluation component. Given the 
challenges to implementation and the large number of 
indicators being collected, the absence of a reference grid 
of minimum indicators to be collected by all programs 
is considered a weakness. By having established select 
required indicators, there would be an assurance of the 
minimum amount of information necessary to compare 
across projects.
Finally, given the nature of many of the projects, there 
are important challenges of finding the appropriate con-
trol groups needed to demonstrate a program’s effect.
Common areas across Theme 1 and 2
The areas that were repeated in both Theme 1 and 2 
included: Lack of funding for research and the need for 
additional resources to sustain implementation and eval-
uation over longer periods of time; Lack of patient refer-
rals by primary care physicians; the short timeline for 
the program implementation and evaluation; the need 
for clinical information systems to facilitate data collec-
tion; communication between all stakeholders is needed 
to legitimize the project for stakeholders to facilitate 
implementation, and boost referrals; implementation 
and evaluation of the programs are easier when there are 
stakeholders that are engaged and interested with a com-
mon vision and goals. Finally the fact that all programs 
are based on the CCM, which is good for comparing 
implementation and possible outcomes across projects. 
The existence of these common themes highlights how 
closely a program’s implementation and its evaluation 
can be interdependent.
Opportunities Theme 1 and 2
Given the influence that success factors and challenges 
for the implementation of the programs have on the 
evaluation component and vice versa, the opportunities 
expressed for both themes during the SWOT analysis are 
presented together.
Involvement of stakeholders and partners
There needs to be an effort to reinforce current partner-
ships and to cultivate new ones. Take referring doctors for 
example. More effort needs to be made to promote the 
programs and their advantages. Primary care physicians 
must be able to recognise the crucial role they play in the 
programs. If they feel more included they will perhaps be 
more willing to refer their patient’s to the programs.
More can also be done to grow community networks. 
Participants express a need to reach out to organizations 
that share a common vision and philosophy towards 
chronic disease management. This includes courting the 
participation of non-traditional partners such as YMCAs, 
pharmacists, fitness centers, etc.
Finally, the opportunity to develop a solid communica-
tion strategy that can be used to market the programs’ 
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advantages to potential partners must be seized. Cer-
tain modalities are worth exploring, notably making use 
of marketing professionals or forming partnerships with 
universities to have marketing students develop a com-
munication strategy for the programs. These partner-
ships could lead to the discovery of more effective ways 
to communicate evaluation results, which can help legiti-
mize the programs and command the attention of poten-
tial partners and decision makers.
Seizing funding opportunities
Equally important for program implementation and eval-
uation is the need to remain vigilant for both traditional 
and alternative sources of public and private funding. 
This also involves capitalizing on existing funding to see 
how it may creatively be used to benefit chronic disease 
management programs. For example, there was recent 
provincial funding to add resources to FMGs. If aware of 
an influx of resources within an organization, programs 
can be designed and implemented in such a way as to 
capitalize on or share these resources thereby increasing 
overall efficiency within an organization.
Knowledge transfer
Perhaps the most widely expressed opportunity was the 
desire to facilitate the sharing of knowledge. The organi-
zation of knowledge translation events such as the one 
being discussed in this paper has been beneficial not 
only to provide a platform for the sharing of information 
and successful strategies but also in facilitating human 
contact between stakeholders. In addition, such events 
have the effect of propagating the synergy between the 
research and clinical teams, which was identified as one 
of the most important strengths to leverage. These events 
can occur more frequently and on a smaller scale by mak-
ing use of existing resources such as local and regional 
tables to share and move ideas forward. By ensuring 
effective knowledge transfer, the current programs and 
future programs will be able to learn from each other 
and use clinical tools, experiences, and models of care 
which have already been proven effective. Finally, another 
opportunity for knowledge translation is ongoing synthe-
sis and publication of facilitators and barriers of chronic 
disease management program implementation and eval-
uation, which can be used to inform current and future 
program planning.
Supporting the transformation of professional roles
As was discussed, one of the most important challenges 
is the transformation of professional roles. This is not 
surprising as it requires both changes within individu-
als and within organizational structures. Members from 
the clinical and evaluation teams alike offered a number 
of opportunities that could help support this change in 
professional roles: (1) review the remuneration of doc-
tors as the current method does not coincide well the 
interdisciplinary format of care delivery; (2) explore 
the use of facilitators as opposed to relying on “medical 
champions” alone whom are not always available, facili-
tators may be in a better position to offer the intensity 
required to ensure transformation of professional roles; 
(3) bring professionals together to ensure the offering 
of identical training to ensure the standardization of 
care and more importantly the consistency of informa-
tion being given to patients; (4) improve the working 
conditions of clinicians which will help incite clinician 
participation in the program and avoid the disruption 
caused when unsatisfied clinicians leave; (5) restructure 
the programs in such a way as to minimize the disrup-
tion caused by clinician turnover; (6) explore different 
types of professional training including courses on how 
to function within an interdisciplinary team and how to 
deliver interventions focused on patient self-manage-
ment; (7) advocate for the reshaping of university cur-
riculums to put greater emphasis on the advantages of 
interdisciplinary care and self-management, which may 
give future health professionals greater exposure to 
these concepts.
Health information technology
Expanding the use of health information technologies 
(HIT) in the healthcare system and in these programs 
was seen as an important opportunity. Many of the par-
ticipants believe that HIT has the potential to facilitate or 
even solve many of the challenges currently facing these 
programs. For example: HIT can (1) facilitate the referral 
process into the program and help referring doctors fol-
low their patient’s progress; (2) facilitate data collection 
to inform clinical decision making and the evaluation; 
(3) facilitate knowledge exchange which is important 
for the functioning of interdisciplinary teams, dissemi-
nation of evaluation results, and maintenance of posi-
tive stakeholder relations; and (4) improve the quality of 
a program’s interventions by providing access to more 
complete medical information and access to decisions 
support.
Cost evaluation
Given the allocation of funds specifically for the evalua-
tion of these programs, many feel that this offers a rare 
opportunity to evaluate the costs involved in implement-
ing the programs and the overall cost-effectiveness of 
these chronic disease management programs. This is a 
good opportunity that can supply invaluable information 
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to decision making at the local, regional, and national 
level. One of the most important strengths for the evalu-
ation of these programs is the similarity they have with 
one another, which allows for comparisons at many lev-
els. However, a barrier to this comparison is that there 
were no minimum indicators identified for all programs 
to adhere to. Therefore, an opportunity would be the cre-
ation of a checklist of common indicators that would be 
used by all programs.
Preliminary recommendations for knowledge transfer
The fact that the seven programs were all operating 
within a similar Quebec context enhanced the opportu-
nity to discuss facilitators and barriers to implementation 
and evaluation. The following recommendations, based 
on the conclusions resulting from the presentations and 
discussions at the knowledge transfer meeting, are tar-
geted to the local, regional, and provincial organizations 
involved in these programs. However, we believe that the 
results presented and the following recommendations are 
useful for organizations implementing similar programs, 
to provide a preliminary roadmap for organizing and 
delivering high-quality care for the prevention and man-
agement of chronic diseases.
Recommendations
  • Dedicate resources and time to the promotion and 
advocacy of chronic disease prevention and manage-
ment programs.
(a) Promote the programs’ existence and advan-
tages (by sharing clinical and evaluation data) 
with community health professionals in order to 
increase program referrals.
(b) Reinforce current partnerships and cultivate 
new ones with community partners (e.g. fitness 
centers and pharmacists).
  • Support the transformation of professional roles to 
be more in line with the current visions of chronic 
disease prevention and management programs.
(a) To compare and evaluate the potential impact of 
different models of remuneration on the imple-
mentation of evidence-based practices
(b) Conduct an environmental scan of the training 
programs in order to identify existing training 
programs, which put an emphasis on the role of 
professionals in the prevention and management 
of chronic disease.
(c) Organize and offer continuing education train-
ing in interdisciplinary teamwork and patient 
self-management for primary care health profes-
sionals and interdisciplinary team members.
(d) Provide training opportunities to support clini-
cians and clinical managers to adopt evaluation 
and feedback as part of their clinical process to 
reflect on current practices and enhance pro-
grams.
(e) Advocate for more inclusion of chronic disease 
prevention and management principles in the 
curriculum of medical, nursing, and allied health 
programs in universities.
  • Implement strategies to facilitate the implementation 
of chronic disease management programs.
(a) Conduct an ongoing environmental scan of 
existing chronic disease management inter-
ventions and programs in each region to avoid 
duplication of services and maximize resources.
(b) Provide human resources to help identify 
opportunities to maximize existing resources 
and facilitate organizational change during the 
implementation of new programs.
(c) In addition to patient referral to chronic disease 
management programs by primary care physi-
cians, provide referral mechanisms from other 
health professionals.
(d) Ensure systematic support for self-management 
strategies.(e.g. motivational approach [22], the 
5A approach [23]).
  • Invest in the acquisition and the implementation 
of health information technologies to facilitate the 
standardized data collection of chronic disease pre-
vention and management programs province-wide. 
These technologies should support and facilitate 
interdisciplinarity.
  • Provide the resources needed to maximize the capac-
ity and efficiency of implementing and evaluating 
chronic disease prevention and management pro-
grams.
(a) Provide the financial resources required to sus-
tain evaluations long enough to produce robust 
results on impact and cost-effectiveness.
(b) Identify a minimum set of impact, process and 
implementation indicators that should be col-
lected by all programs to facilitate comparisons 
of programs and impact on patient and primary 
care outcomes across projects.
  • Dedicate financial and human resources for the plan-
ning of knowledge translation activities.
Conclusion
Implementation of chronic disease management pro-
grams is complex. Comparison across programs currently 
being implemented provides the opportunity to identify 
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common challenges and success factors for the delivery 
of interdisciplinary care for chronic conditions integrated 
into primary care. We do, however, caution that this rep-
resents a limitation for generalizing the results to other 
settings outside of Quebec. While many of the themes 
are in line with the literature on implementation theory, 
we recommend consulting a comprehensive theoreti-
cal framework, such as the Consolidated Framework for 
Implementation Research [24], to help guide the imple-
mentation of the presented recommendations in order to 
ensure relevance based on the setting.
Our synthesis across seven chronic disease programs 
identified the need to actively engage primary care physi-
cians so that they may recognise the benefits and increase 
patient referral to the programs. In addition, mechanisms 
are needed to optimise access to chronic disease man-
agement programs and to avoid duplication of services. 
Further, working as an interdisciplinary team to support 
patients to help them develop the skills they need to take 
an active role in their care is new for many clinicians. A 
shift is needed in the way health professionals are trained 
to be more in line with the principles of chronic dis-
ease management. Within programs, technology will be 
key for facilitating the collection of clinical and patient 
reported data to feedback this information to inform 
clinical decision-making and to allow for ongoing evalu-
ation and improvement of programs. Finally, a culture 
shift to drive home the importance of measurement and 
reflection of clinician practices is essential for ongoing 
improvement and sustainability of chronic disease man-
agement programs. A network for continuing knowledge 
translation between researchers, clinicians, patients, and 
decision makers will be necessary to speed up the imple-
mentation of best practice for chronic diseases by imple-
menting strategies found to facilitate implementation.
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